Archive:
Apr 29, 2022, 12:00 AM

JelikaLite Awarded NSF SBIR Phase 1 Grant for EEG-Guided Intelligent Transcranial Photobiomodulation to Reduce Symptoms of Autism
April
29,
2022
We are thrilled to announce that client, JelikaLite, was awarded a National Science Foundation grant SBIR Phase 1: "EEG-guided intelligent transcranial photobiomodulation to reduce symptoms of autism".
Read More »